Related Experiment Video
Updated: May 3, 2026

A 5-mC Dot Blot Assay Quantifying the DNA Methylation Level of Chondrocyte Dedifferentiation In Vitro
Published on: May 17, 2017
Dexamethasone reduces ATDC5 chondrocyte cell viability by inducing autophagy
Yan Zhao1, Yuan Zuo2, Hongjun Huo1
1Department of Spine Surgery, The Second Affiliated Hospital of Inner Mongolia Medical University, Huimin, Hohhot, Inner Mongolia Autonomous Region 010058, P.R. China.
Abstract:
Prolonged use of glucocorticoids (GCs) for the treatment of chronic inflammatory and autoimmune diseases commonly exerts various side-effects, including impairment of skeletal development. However, the effect of GCs on chondrocytes, which play a key role in skeletal development, has been rarely reported. In the present study, autophagy was induced in the ATDC5 chondrocyte cell line following treatment with dexamethasone (Dex) at doses of 1‑100 µM, and that this effect can be inhibited by RU486, a GC antagonist. Autophagy induced by the highest Dex dose (100 µM) was associated with a reduction in ATDC5 cell viability. We conclude that high doses of GC can reduce ATDC5 chondrocyte cell viability by inducing autophagy.
Insights
High-dose glucocorticoids (GCs) induce autophagy in chondrocytes, reducing cell viability. This effect, observed in ATDC5 cells with dexamethasone, was blocked by a GC antagonist, highlighting a mechanism for GC-induced skeletal impairment.
Area of Science:
- Cell Biology
- Endocrinology
- Skeletal Development
Background:
- Glucocorticoids (GCs) are widely used for chronic inflammatory and autoimmune diseases.
- Prolonged GC use can impair skeletal development, but effects on chondrocytes are understudied.
- Chondrocytes are crucial for skeletal development.
Purpose of the Study:
- To investigate the effects of GCs on chondrocytes.
- To determine if GCs induce autophagy in chondrocytes.
- To examine the impact of GC-induced autophagy on chondrocyte viability.
Main Methods:
- Treatment of ATDC5 chondrocyte cell line with varying doses of dexamethasone (Dex).
- Assessment of autophagy induction.
- Administration of RU486, a GC antagonist, to inhibit GC effects.
- Evaluation of ATDC5 cell viability.
Main Results:
- Dexamethasone (Dex) induced autophagy in ATDC5 chondrocytes in a dose-dependent manner (1-100 µM).
- Autophagy induction by Dex was reversible with the GC antagonist RU486.
- High-dose Dex (100 µM) significantly reduced ATDC5 chondrocyte viability.
- Autophagy induction correlated with decreased chondrocyte viability.
Conclusions:
- High doses of GCs can induce autophagy in chondrocytes.
- GC-induced autophagy in chondrocytes leads to reduced cell viability.
- This mechanism may contribute to GC-induced skeletal development impairment.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Cellular Injury V: Apoptosis and Autophagy
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...

